Trading Signals: ARNA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Thu. Mar. 10, 2022)(Arena Pharmaceuticals)
| Market is closed on Mon. Apr. 11, 2022 | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 0% (three month average) | | RSI | | | Latest Price | $(0%) | | Stocks Behave Similarly | Similar Stock List | | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | | Correlated ETFs | Broad market will support ARNA advance at 0% a week (0% probability)
(0%) (0%) (0%) (0%) (0%) | | Factors Impacting ARNA price | ARNA will advance at least -0% in a week (0% probabilities).
(0%) (0%) (0%) (0%) (0%) | | | | | | | | Relative Volatility | | | | | | Market Trend Strength | 0% (StdDev 0%) | | Hourly BBV | 0 () | | Intraday Trend | NAN% | | | | | |
|
Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in San Diego, CA. |